Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of British Columbia

$23,800.00

Concise enantioselective synthesis of d- and l-Govadine

EF 2011-12

Résumé
Neuropsychiatric diseases are chronic and debilitating neurological disorders, many of which have no cure. Of specific interest are tetrahydroprotoberberines (THPBs) as potential pharmaceutical agents. THPBs are alkaloids isolated from a variety of plant species including those of the Corydalis and Stephania genus. A prototypical example is l-govadine, which shows significant promise in the treatment of neuropsychiatric diseases based on unique pharmacological activity. Investigations of biological activity and subsequent clinical research require significant amounts of enantioenriched material. Since THPBs are naturally available in extremely low concentrations the development of convenient and scalable synthetic routes to these highly bioactive compounds is extremely desirable. The goal of this project is to develop an efficient enantioselective synthetic route to d- and l-govadine, and related THPBs.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
412346-2010
Name nom
Sammis, Glenn
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
23800
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Concise enantioselective synthesis of d- and l-Govadine
Keyword
NSERC
Application summary
Neuropsychiatric diseases are chronic and debilitating neurological disorders, many of which have no cure. Of specific interest are tetrahydroprotoberberines (THPBs) as potential pharmaceutical agents. THPBs are alkaloids isolated from a variety of plant species including those of the Corydalis and Stephania genus. A prototypical example is l-govadine, which shows significant promise in the treatment of neuropsychiatric diseases based on unique pharmacological activity. Investigations of biological activity and subsequent clinical research require significant amounts of enantioenriched material. Since THPBs are naturally available in extremely low concentrations the development of convenient and scalable synthetic routes to these highly bioactive compounds is extremely desirable. The goal of this project is to develop an efficient enantioselective synthetic route to d- and l-govadine, and related THPBs.